This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADSC:
-
Adipose tissue-derived stem cell
- AML:
-
Acute myeloid leukemia
- BP:
-
Boesenbergia pandurata
- DNA:
-
Deoxyribonucleic acid
- HPLC:
-
High Performance Liquid Chromatography
- HSPCs:
-
Hematopoietic stem and progenitor cells
- PBS:
-
Phosphate-buffered saline
- SEI:
-
Side index effect
References
Atjanasuppat, K., Wongkham, W., Meepowpan, P., Kittakoop, P., Sobhon, P., Bartlett, A., & Whitfield, P. J. (2009). In vitro screening for anthelmintic and antitumour activity of ethnomedicinal plants from Thailand. Journal of Ethnopharmacology, 123(3), 475–482.
Bao, X. Q., & Liu, G. T. (2008). Bicyclol: A novel antihepatitis drug with hepatic heat shock protein 27/70-inducing activity and cytoprotective effects in mice. Cell Stress & Chaperones, 13(3), 347–355.
Casorelli, I., Offman, J., Mele, L., Pagano, L., Sica, S., D’Errico, M., Giannini, G., Leone, G., Bignami, M., & Karran, P. (2003). Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome. DNA Repair (Amst), 2(5), 547–559.
Choi, Y., Kim, M. S., & Hwang, J. K. (2012). Inhibitory effects of panduratin A on allergy-related mediator production in rat basophilic leukemia mast cells. Inflammation, 35(6), 1904–1915.
George, S., Bhalerao, S. V., Lidstone, E. A., Ahmad, I. S., Abbasi, A., Cunningham, B. T., & Watkin, K. L. (2010). Cytotoxicity screening of Bangladeshi medicinal plant extracts on pancreatic cancer cells. BMC Complementary and Alternative Medicine, 10, 52.
Granfeldt Ostgard, L. S., Medeiros, B. C., Sengelov, H., Norgaard, M., Andersen, M. K., Dufva, I. H., Friis, L. S., Kjeldsen, E., Marcher, C. W., Preiss, B., et al. (2015). Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: A National Population-Based Cohort Study. Journal of Clinical Oncology, 33(31), 3641–3649.
Guillem, V., & Tormo, M. (2008). Influence of DNA damage and repair upon the risk of treatment related leukemia. Leukemia & Lymphoma, 49(2), 204–217.
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014). Clinical development success rates for investigational drugs. Nature Biotechnology, 32(1), 40–51.
Holmes, F. A., Walters, R. S., Theriault, R. L., Forman, A. D., Newton, L. K., Raber, M. N., Buzdar, A. U., Frye, D. K., & Hortobagyi, G. N. (1991). Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. Journal of the National Cancer Institute, 83(24), 1797–1805.
Karmakar, U. K., Ishikawa, N., Arai, M. A., Ahmed, F., Koyano, T., Kowithayakorn, T., & Ishibashi, M. (2016). Boesenberols, pimarane diterpenes with TRAIL-resistance-overcoming activity from Boesenbergia pandurata. Journal of Natural Products, 79(8), 2075–2082.
Lambrechts, T., Sonnaert, M., Schrooten, J., Luyten, F. P., Aerts, J. M., & Papantoniou, I. (2016). Large-scale mesenchymal stem/stromal cell expansion: A visualization tool for bioprocess comparison. Tissue Engineering. Part B, Reviews, 22(6), 485–498.
Ledford, H. (2011). Translational research: 4 ways to fix the clinical trial. Nature, 477(7366), 526–528.
Li, M., & Liu, G. T. (2004). Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol. World Journal of Gastroenterology, 10(12), 1775–1779.
Marchetti, S., & Schellens, J. H. (2007). The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. British Journal of Cancer, 97(5), 577–581.
Schmidt, M., Gutknecht, D., Simon, J. C., Schulz, J. N., Eckes, B., Anderegg, U., & Saalbach, A. (2015). Controlling the balance of fibroblast proliferation and differentiation: Impact of Thy-1. The Journal of Investigative Dermatology, 135(7), 1893–1902.
Sorrell, J. M., & Caplan, A. I. (2004). Fibroblast heterogeneity: More than skin deep. Journal of Cell Science, 117(Pt 5), 667–675.
Sun, H., Yu, L., Wei, H., & Liu, G. (2012). A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model. Journal of Biomedicine & Biotechnology, 2012, 584728.
Van Pham, P., Vu, N. B., Phan, N. L.-C., Le, D. M., Truong, N. C., Truong, N. H., Bui, K. H.-T., & Phan, N. K. (2014). Good manufacturing practice-compliant isolation and culture of human adipose-derived stem cells. Biomedical Research and Therapy, 1(04), 133–141.
Wani, M. C., & Horwitz, S. B. (2014). Nature as a remarkable chemist: A personal story of the discovery and development of Taxol. Anti-Cancer Drugs, 25(5), 482–487.
Acknowledgments
This work was supported by the Vietnam National University, Ho Chi Minh City, Vietnam, under grant A2015-18-01.
Conflicts of Interest
The authors declare that there is no conflict of interests regarding the publication of this article.
Authors Contributions
Mai Thi Thanh Nguyen, Nhan Trung Nguyen, and Hai Xuan Nguyen prepared the plant extracts. Sinh Truong Nguyen, Nghia Minh Do, and Phuc Hong Vo performed the experiments. Sinh Truong Nguyen wrote the manuscript. Kiet Dinh Truong and Phuc Van Pham finally edited the manuscript.
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Sinh Truong Nguyen. et al. (2020). Selective Cytotoxicity of Some Plant Extracts Against Hepatocellular Carcinoma Cells but Not Mesenchymal Stem Cells: A Pilot Screening. In: Pham, P.V. (eds) Cancer Biology and Advances in Treatment. Advances in Experimental Medicine and Biology(), vol 1292. Springer, Cham. https://doi.org/10.1007/5584_2020_525
Download citation
DOI: https://doi.org/10.1007/5584_2020_525
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57253-2
Online ISBN: 978-3-030-57254-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)